Behavioral and pharmacogenetics of aggressive behavior

Area of Science:

• Neuroscience
• Behavioral Science
• Pharmacology

Background:

• Serotonin (5-HT) is a critical neurotransmitter implicated in regulating aggression.
• Dysregulation of 5-HT receptors, transporters, and enzymes is linked to impulsive aggression.
• Recent research integrates pharmacological and genetic findings to elucidate 5-HT's role.

Purpose of the Study:

• To summarize recent pharmacological and genetic studies on serotonin's role in aggression.
• To explore the complex interactions between 5-HT system components and other neurochemical systems.
• To highlight region-specific and receptor-subtype-specific effects on aggression.

Main Methods:

• Review of pharmacological studies, including local intracranial microinjections.
• Analysis of genetic studies, including gene polymorphisms and manipulations in animal models.
• Examination of gene-environment interactions influencing aggression.

Main Results:

• Pharmacological and genetic approaches yield sometimes inconsistent aggression modulation due to differing effects (phasic vs. trait-like).
• Activation of 5-HT1A and 5-HT1B receptors in specific brain regions differentially impacts aggression: reduction in mesocorticolimbic areas, escalation in medial prefrontal cortex/septal area.
• Genetic variations (e.g., MAOA polymorphisms) and gene-environment interactions influence aggression vulnerability.
• Interactions with GABA, glutamate, CRF, and neuropeptides (vasopressin, oxytocin, NPY, opioids) are crucial neurobiological determinants.
• Studies in genetically modified mice identified key molecules (e.g., Tph2, 5-HT1B, MAOA, BDNF, nNOS) affecting the 5-HT system and aggression.

Conclusions:

• Specific 5-HT receptor populations within distinct brain regions selectively modulate different forms of aggression.
• Gene-environment interactions are critical for understanding aggression vulnerability.
• The 5-HT system interacts intricately with other neurotransmitter and neuropeptide systems to regulate aggressive behaviors.
• Future research should target specific receptor subpopulations and their interactions for potential therapeutic interventions.